CompletedNCT02709018
Losartan for PTSD Symptoms
About this title
A Controlled Trial of Losartan in Posttraumatic Stress Disorder
Read the official source — NCT02709018Researchers compared losartan and placebo to find out how the approaches affected post-traumatic stress symptoms in people with PTSD.
Medication studyAges 18–70United States
Understand this study
What did researchers investigate?
Researchers compared losartan and placebo to find out how the approaches affected post-traumatic stress symptoms in people with PTSD.
Who was this study for?
Listed age limits: 18 years to 70 years.
- Listed locations
- La Jolla and 5 more locationsSee all locations and recruitment
Study information
Study start dateStarted: July 16, 2016
- Recruitment status
- Completed
- Enrollment listed in the registry
- 149
- Sponsor
- University of California, San Diego
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Locations
- United States
- Age range
- From 18 Years to 70 Years
- Official registry ID
- NCT02709018
- Official title
Show the full official title
Enhancing Fear Extinction Via Angiotensin Type 1 Receptor Inhibition: A Randomized Controlled Trial in Posttraumatic Stress Disorder
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
La Jolla · Washington D.C. · Bethesda
3 more locations
- Belmont
- Boston
- New York
Interested in joining this study?
Questions about this study
What did researchers investigate?
Researchers compared losartan and placebo to find out how the approaches affected post-traumatic stress symptoms in people with PTSD.
Who is behind this study?
The study sponsor is University of California, San Diego, a university.
Did this study involve medication?
Yes. The study involved medication, including losartan and Placebo.
Who was this study for?
Listed age limits: 18 years to 70 years.
